These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1514 related articles for article (PubMed ID: 29225343)

  • 41. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern.
    Ebner S; Hofer S; Nguyen VA; Fürhapter C; Herold M; Fritsch P; Heufler C; Romani N
    J Immunol; 2002 Jun; 168(12):6199-207. PubMed ID: 12055233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor.
    Randow F; Döcke WD; Bundschuh DS; Hartung T; Wendel A; Volk HD
    J Immunol; 1997 Mar; 158(6):2911-8. PubMed ID: 9058829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
    Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
    J Infect Dis; 1999 Apr; 179(4):1038-41. PubMed ID: 10068606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flt3 Ligand Treatment Attenuates T Cell Dysfunction and Improves Survival in a Murine Model of Burn Wound Sepsis.
    Patil NK; Bohannon JK; Luan L; Guo Y; Fensterheim B; Hernandez A; Wang J; Sherwood ER
    Shock; 2017 Jan; 47(1):40-51. PubMed ID: 27454384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction.
    Presneill JJ; Harris T; Stewart AG; Cade JF; Wilson JW
    Am J Respir Crit Care Med; 2002 Jul; 166(2):138-43. PubMed ID: 12119223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Past, Present, and Future of Augmentation of Monocyte Function in the Surgical Patient.
    Galbraith N; Walker S; Carter J; Polk HC
    Surg Infect (Larchmt); 2016 Oct; 17(5):563-9. PubMed ID: 27309382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine.
    Block MS; Suman VJ; Nevala WK; Kottschade LA; Creagan ET; Kaur JS; Quevedo JF; McWilliams RR; Markovic SN
    Melanoma Res; 2011 Oct; 21(5):438-45. PubMed ID: 21697748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sepsis, immunosuppression and the role of epigenetic mechanisms.
    Córneo EDS; Michels M; Dal-Pizzol F
    Expert Rev Clin Immunol; 2021 Feb; 17(2):169-176. PubMed ID: 33596148
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
    Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
    Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
    Ratta M; Curti A; Fogli M; Pantucci M; Viscomi G; Tazzari P; Fagnoni F; Vescovini R; Sansoni P; Tura S; Lemoli RM
    Exp Hematol; 2000 Aug; 28(8):931-40. PubMed ID: 10989194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunosuppression in sepsis.
    Lyn-Kew K; Standiford TJ
    Curr Pharm Des; 2008; 14(19):1870-81. PubMed ID: 18691098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune-mediated side-effects of cytokines in humans.
    Vial T; Descotes J
    Toxicology; 1995 Dec; 105(1):31-57. PubMed ID: 8638283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.
    Guo X; Higgs BW; Bay-Jensen AC; Wu Y; Karsdal MA; Kuziora M; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Rheumatology (Oxford); 2018 Jan; 57(1):175-184. PubMed ID: 29069507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune disorders in sepsis and their treatment as a significant problem of modern intensive care.
    Łysenko L; Leśnik P; Nelke K; Gerber H
    Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):703-712. PubMed ID: 28894043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nfia deletion in myeloid cells blocks expansion of myeloid-derived suppressor cells during sepsis.
    Dai J; Kumbhare A; Williams DA; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    Innate Immun; 2018 Jan; 24(1):54-65. PubMed ID: 29172874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Review of GM-CSF Therapy in Sepsis.
    Mathias B; Szpila BE; Moore FA; Efron PA; Moldawer LL
    Medicine (Baltimore); 2015 Dec; 94(50):e2044. PubMed ID: 26683913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting dendritic cell function during systemic autoimmunity to restore tolerance.
    Mackern-Oberti JP; Vega F; Llanos C; Bueno SM; Kalergis AM
    Int J Mol Sci; 2014 Sep; 15(9):16381-417. PubMed ID: 25229821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.
    Cheng SC; Scicluna BP; Arts RJ; Gresnigt MS; Lachmandas E; Giamarellos-Bourboulis EJ; Kox M; Manjeri GR; Wagenaars JA; Cremer OL; Leentjens J; van der Meer AJ; van de Veerdonk FL; Bonten MJ; Schultz MJ; Willems PH; Pickkers P; Joosten LA; van der Poll T; Netea MG
    Nat Immunol; 2016 Apr; 17(4):406-13. PubMed ID: 26950237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.